DGAT-1 inhibitors (Sanofi)

N/A

Report date: 2025/03/18 20:00:05

NME

Base Information

Drug NameDGAT-1 inhibitors (Sanofi)

Drug Alias Namediacylglycerol acyltransferase 1 inhibitors (Sanofi-Aventis)

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionDiacylglycerol O-acyltransferase 1 inhibitors

TargetsDiacylglycerol O-acyltransferase 1

Therapy Area/IndicationsMetabolic Diseases

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryGermanyFrance

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesSanofi

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesSanofi

Active IndicationsN/A

Inactive IndicationsMetabolic Diseases

ATC CodeN/A